FUSN: Fusion Pharmaceuticals Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,819.96
Enterprise Value ($M) 1,793.28
Book Value ($M) 222.48
Book Value / Share 2.62
Price / Book 8.18
NCAV ($M) 180.04
NCAV / Share 2.12
Price / NCAV 10.11

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.47

Liquidity (mrq)
Quick Ratio 15.01
Current Ratio 15.01

Balance Sheet (mrq) ($M)
Current Assets 243.40
Assets 285.84
Liabilities 63.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.07
Operating Income -99.23
Net Income -94.90
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -81.80
Cash from Investing -42.76
Cash from Financing 142.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-08 13G/A Federated Hermes, Inc. 0.11 -99.11
03-20 13D/A HealthCap VII, L.P. 4.50 0.00
02-14 13G/A Canada Pension Plan Investment Board 4.30 0.00
02-13 13G/A Avidity Partners Management LP 8.10 -4.75
02-09 13G/A Fmr Llc 7.34 97.37
01-19 13G Perceptive Advisors Llc 6.50
12-18 13G Flynn James E 8.84
05-16 13D/A Orbimed Advisors Llc 4.60 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-12 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-29 32,188 446,689 7.21
2024-04-26 34,554 111,929 30.87
2024-04-25 41,432 147,186 28.15
2024-04-24 23,469 77,099 30.44

(click for more detail)

Similar Companies
FDMT – 4D Molecular Therapeutics, Inc. FGEN – FibroGen, Inc.
FNCH – Finch Therapeutics Group, Inc. GBIO – Generation Bio Co.
GERN – Geron Corporation


Financial data and stock pages provided by
Fintel.io